InvestSMART

Greencross Limited (ASX: GXL) - Announcements

DELISTED - Current share price for GXL : $5.540

ASX company news and announcements for Greencross Limited (GXL) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Greencross Limited (GXL) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Greencross Limited (GXL), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Greencross Limited (GXL)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
- Acquisition of 8% interest in PAE & Appendix 3B 5 Feb 2013 11:40AM $3.850 $5.540 risen by 43.90%
- Acquisition of 44% interest in GXSC & Appendix 3B 30 Jan 2013 5:40PM $3.680 $5.540 risen by 50.54%
- Profit Guidance First Half 2013 25 Jan 2013 10:06AM $3.650 $5.540 risen by 51.78%
- Greencross Acquires New Clinic 19 Dec 2012 12:31PM $3.350 $5.540 risen by 65.37%
- Accounting Treatment of Deferred Purchase Price 18 Dec 2012 6:31PM $3.260 $5.540 risen by 69.94%
- Acquisition of 49% interest in GVT & Appendix 3B 14 Dec 2012 8:24AM $3.200 $5.540 risen by 73.13%
- Greencross Acquires 3 New Clinics 19 Nov 2012 1:20PM $3.220 $5.540 risen by 72.05%
- Chairman's Address to Shareholders 25 Oct 2012 1:03PM $3.100 $5.540 risen by 78.71%
- Greencross Acquires Two New Vet Practices 5 Oct 2012 10:02AM $2.940 $5.540 risen by 88.44%
- Open Briefing - CEO on Results and FY2013 Outlook 27 Aug 2012 2:44PM $2.690 $5.540 risen by 105.95%
- Investor Presentation August 2012 23 Aug 2012 9:24AM $2.650 $5.540 risen by 109.06%
- Appendix 4E & Full Year Statutory Accounts 22 Aug 2012 3:37PM $2.700 $5.540 risen by 105.19%
- Greencross Acquires Three Vet Practices 12 Jul 2012 8:24AM $2.270 $5.540 risen by 144.05%
- Open Briefing - MD on Vet Pathology Business and Outlook 5 Jun 2012 9:20AM $2.100 $5.540 risen by 163.81%
- Greencross Acquires Two Vet Practices 25 May 2012 8:25AM $2.000 $5.540 risen by 177%
- Greencross Invests in Veterinary Pathology Business 21 May 2012 2:09PM $1.900 $5.540 risen by 191.58%
- Open Briefing - Additional Debt Funding and Outlook 2 May 2012 11:24AM $1.980 $5.540 risen by 179.80%
- Greencross Secures Additional Funidng of $12m 26 Apr 2012 12:58PM $2.050 $5.540 risen by 170.24%
- Acquisition - Kelso Vet Clinic 7 Mar 2012 11:27AM $1.860 $5.540 risen by 197.85%
- Half Yearly Report and Accounts 29 Feb 2012 2:08PM $2.030 $5.540 risen by 172.91%
- Acquisition - Maitland Vet Hospital 1 Feb 2012 10:17AM $1.620 $5.540 risen by 241.98%
- Acquisition - Morwell, Barolin and Pakenham 15 Nov 2011 2:40PM $1.200 $5.540 risen by 361.67%
- Open Briefing - CEO on FY2012 Outlook and Strategy 13 Oct 2011 9:33AM $1.050 $5.540 risen by 427.62%
- Acquisition - Hurstbridge 13 Sep 2011 8:47AM $1.090 $5.540 risen by 408.26%
- Acquisition - Livingstone Road Animal Health Centre 29 Aug 2011 8:39AM $1.140 $5.540 risen by 385.96%

276 - 300 of 357 results

Page 12 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.